| Literature DB >> 32556263 |
David Roy1, Kevin T Huguet1, Frédéric Grenier1, Vincent Burrus1.
Abstract
Bacteria have evolved defence mechanisms against bacteriophages. Restriction-modification systems provide innate immunity by degrading invading DNAs that lack proper methylation. CRISPR-Cas systems provide adaptive immunity by sampling the genome of past invaders and cutting the DNA of closely related DNA molecules. These barriers also restrict horizontal gene transfer mediated by conjugative plasmids. IncC conjugative plasmids are important contributors to the global dissemination of multidrug resistance among pathogenic bacteria infecting animals and humans. Here, we show that IncC conjugative plasmids are highly resilient to host defence systems during entry into a new host by conjugation. Using a TnSeq strategy, we uncover a conserved operon containing five genes (vcrx089-vcrx093) that confer a novel host defence evasion (hde) phenotype. We show that vcrx089-vcrx090 promote resistance against type I restriction-modification, whereas vcrx091-vcxr093 promote CRISPR-Cas evasion by repairing double-strand DNA breaks via recombination between short sequence repeats. vcrx091, vcrx092 and vcrx093 encode a single-strand binding protein, and a single-strand annealing recombinase and double-strand exonuclease related to Redβ and λExo of bacteriophage λ, respectively. Homologous genes of the integrative and conjugative element R391 also provide CRISPR-Cas evasion. Hence, the conserved hde operon considerably broadens the host range of large families of mobile elements spreading multidrug resistance.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32556263 PMCID: PMC7498323 DOI: 10.1093/nar/gkaa518
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Insertion of O395 protospacers in pVCR94 reduces its transfer to Cas+V. cholerae O395. (A) Sequence of the protospacers introduced into pVCR94Sp. (B) Conjugative transfer of pVCR94Sp derivatives bearing O395 protospacers from E. coli VB111 to V. cholerae O395R (Cas+) or O395RΔcas (Cas−). (C) Impact of protospacer insertion site on the transfer of pVCR94Sp to O395R. Positions of V1 protospacer insertions are indicated by orange arrowheads in Figure 2B. Bars are the mean of three independent experiments. Error bars are the standard error of the mean. Statistical significance: ****P< 0.0001 and ***P< 0.001.
Figure 2.Identification of CRISPR and restriction evasion functions by TnSeq. (A) Overview of the TnSeq workflow for the identification of anti-CRISPR functions in the IncC plasmid pVCR94. (B) A cluster of five genes is essential for the transfer of pVCR94Kn-V1 from E. coli VB111 to V. cholerae O395R (Cas+) but not O395RΔcas (Cas−). The three first tracks plot the number of mini-Tn5 reads mapped as a function of the position in pVCR94Kn-V1 (black bars). (C) Plot of mini-Tn5 insertion index for each gene (vcrx) of pVCR94Kn-V1. Insertion indexes were calculated as the ratios of insertion counts between O395RΔcas and O395R. Genes are color-coded as in panel b. (D) hde genes are part of a single operon. A 2% agarose gel from an assay to amplify genes of the hde locus on the vcrx094-derived reverse transcripted RNA. Genomic DNA of VB111 carrying pVCR94Sp (gDNA) and reverse transcription samples in the absence of reverse transcriptase (‘noRT’) were used as positive and negative PCR controls, respectively. M, 100 bp Plus II DNA ladder (Civic Bioscience).
Figure 3.hde genes impact the resilience of translocated DNA against DNA cleavage in recipient cells during conjugation. (A) Effect of vcrx089/090 on transfer of pVCR94Sp with or without protospacer V1 using O395R as the recipient. Complementation of the Δ(vcrx089-090) mutation was carried out using pVcrx089-90 in either donor (D) or recipient (R) cells. (B) Effect of vcrx089/090 on transfer of pVCR94Sp devoid of protospacer using O395R and it restriction deficient ΔhsdR mutant or VB112 as the recipient. The pattern recognized by the type I R-M enzyme of each recipient is indicated. The corresponding number of sites in pVCR94Sp is shown in parenthesis. (C) Effect of ssb, bet and exo on transfer of pVCR94Sp with or without protospacer V1 using O395R or its Δcas mutant as the recipient. Complementation of the Δ(ssb-exo) mutation was carried out using pSsbBetExo in either donor (D) or recipient (R) cells. (D) Effect of bet and exo on the transfer of R391 with or without protospacer V1 using O395R as the recipient. (E) Effect of recA in recipient cells on transfer pVCR94Sp with or without protospacer V1. For all mating assays, E. coli VB111 containing pVCR94Sp variants was used as the donor strain and transconjugants were selected as Rf Sp-resistant colonies. Bars are the mean of three independent experiments. Errors bars are the standard error of the mean. An ‘x’ indicates that the frequency of transconjugant formation was below the detection limit (<10−7). Statistical significance: ****P< 0.0001; ***P< 0.001; *P< 0.05; ns, not statistically significant.
Summary of the scar patterns found in rescued pVCR94Sp carrying V1 protospacer at diverse positions
| Protospacer position | Number of sequenced clonesa | Type of scarsb (distribution) | Conjugation properties | Repeat ID used for repairc | Deletion size (bp)d |
|---|---|---|---|---|---|
| 5 | 73/85 | IA (43/85) | Transmissible | rptIb-rptIf | 23 702 |
| IB (1/85) | Transmissible | rptIb-rptIf | 23 702 | ||
| IC (7/85) | Transmissible | rptIb-rptIe | 14 076 | ||
| ID (1/85) | Transmissible | rptIb-rptIe | 14 076 | ||
| IE (1/85) | Transmissible | rptIb-rptId | 14 003 | ||
| IF (4/85) | Transmissible | rptIb-rptIc | 10 310 | ||
| IG (16/85) | Transmissible | rptIa-rptIc | 9268 | ||
| 1 | 0/85 | No scar | NA | NA | |
| 7 | 1/85 | III (1/85) | Deficient | rptIIIc-rptIIId | 6728 |
| 3 | 2/85 | IV (2/85) | Deficient | rptIIIa-rptIIIb | 59 432 |
| 6 | 9/85 | VA (1/85) | Transmissible | rptIIa-rptIIb | 5138 |
| VB (8/85) | Transmissible | rptIVa-rptIVb | 4936 | ||
| 2 | 0/85 | No scar | NA | NA | |
| 4 | 0/85 | No scar | NA | NA |
a0 values, no repaired transconjugants was obtained.
bPartial sequences of characterized scars are available in Supplemental Figure S2.
cAs depicted in Figure 2B. Sequences of repeat IDs are shown in Table 2. NA, not applicable.
dExact deletion size from pVCR94Sp-V1 variants
Repeated sequence motifs recombined in repaired plasmids
|
|